Ledger.Open graph →
SEC Form D · Amendment · filed February 17, 2016

Chase Pharmaceuticals Corp

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Washington, DC, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Nayan G. Parekh · Washington, DC, Washington, D.C.DirectorVikram M. Sudarsan · Washington, DC, Washington, D.C.DirectorKathleen N. Clarence-Smith · Washington, DC, Washington, D.C.ExecJohn M. Reher · Washington, DC, Washington, D.C.Exec · DirectorStephen N. Cunningham · Washington, DC, Washington, D.C.DirectorRaphael M. Wisniewski · Washington, DC, Washington, D.C.DirectorThomas N. Chase · Washington, DC, Washington, D.C.Exec · DirectorKaroly N. Nikolich · Washington, DC, Washington, D.C.DirectorDouglas Ingram · Washington, DC, Washington, D.C.DirectorScott B. Garfield · BOSTON, MADirectorScott A. Mcfetridge · BOSTON, MAExecBob M. Flannery · Chicago, ILDirectorThomas F. Mcdevitt · Southport, CTExec · DirectorJason A. Darrah · St. Louis, MODirectorA. T. Spitzer · St. Louis, MODirectorJoseph W. Panter · Paradise Valley, AZDirectorMichael H. House · Southport, CTDirectorMarc Platt · Universal City, CADirectorFrank Yulin Yao · Central, Hong KongExec · DirectorBrian A. Albert · BOSTON, MADirectorSaverio R. Costa · BOSTON, MAExec · DirectorStephen J. Blewitt · BOSTON, MAExec · DirectorBenjamin Blumenthal · Carrollton, TXDirectorJeanine Johnson · Carrollton, TXExecJared L. Lucero · Alpine, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗